The Biologics Contract Manufacturing Market is poised for exceptional growth from 2025 to 2033, fueled by the expanding biopharmaceutical industry, the increasing complexity of biologic drugs, and the growing preference among pharmaceutical and biotechnology companies for outsourced manufacturing. The market is projected to be valued at approximately USD 23.6 billion in...
